Atopic Dermatitis (Atopic Eczema) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500

Atopic Dermatitis is an itchy inflammation of skin. Signs and symptoms of Atopic Dermatitis include red to brownish-gray colored patches, itching, which may be severe, especially at night, small, raised bumps, which may leak fluid and crust over when scratched, thickened, cracked or scaly skin and raw, sensitive skin from scratching. Risk factors include family history of eczema, allergies, hay fever or asthma and gender.

The Atopic Dermatitis – Drugs In Development research report provides a comprehensive overview on the therapeutics under development for Atopic Dermatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.  The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.  Additionally, the report provides an overview of key players involved in therapeutic development for Atopic Dermatitis and features dormant and discontinued projects.

Key Targets in the Atopic Dermatitis Pipeline Drugs Market

The key targets in the Atopic Dermatitis pipeline drugs market are Phosphodiesterase 4, Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, Filaggrin, Liver X Receptor, 16S Ribosomal RNA, Angiopoietin 1 Receptor, and Caspase 1 among others.

Atopic Dermatitis Drugs Market, by Targets

Atopic Dermatitis Drugs Market, by Targets

For more target insights, download a free report sample

Key MoA in the Atopic Dermatitis Pipeline Drugs Market

The key mechanisms of action in the Atopic Dermatitis pipeline drugs market are Phosphodiesterase 4 Inhibitor, Tyrosine Protein Kinase JAK1 Inhibitor, Interleukin 4 Receptor Subunit Alpha Antagonist, Interleukin 13 Inhibitor, Sphingosine 1-Phosphate Receptor 1 Agonist, and Tyrosine Protein Kinase JAK3 Inhibitor among others.

Atopic Dermatitis Pipeline Drugs Market, by MoA

Atopic Dermatitis Pipeline Drugs Market, by MoA

To get more insights on key MoA, download a free sample report

Atopic Dermatitis Pipeline Drugs Market Segmentation by RoA

The key routes of administration in the Atopic Dermatitis pipeline drugs market are Topical, Subcutaneous, Intravenous, Oral, Inhalational, Rectal, Ophthalmic, and Parenteral.

Atopic Dermatitis Pipeline Drugs Market Analysis, by RoA

Atopic Dermatitis Pipeline Drugs Market Analysis, by RoA

To get more insights on key RoA, download a free sample report

Key Molecule Types in the Atopic Dermatitis Pipeline Drugs Market

The key molecule types in the Atopic Dermatitis pipeline drugs market are Monoclonal Antibody, Small Molecule, Recombinant Protein, Fusion Protein, Cell Therapy, Synthetic Peptide, and Biologic among others.

Atopic Dermatitis Pipeline Drugs Market, by Molecule Type

Atopic Dermatitis Pipeline Drugs Market, by Molecule Type

To get more insights on key molecule types, download a free sample report

Major Companies in the Atopic Dermatitis Pipeline Drugs Market

The major companies in the Atopic Dermatitis pipeline drugs market are Pfizer Inc, Bristol-Myers Squibb Co, Dermavant Sciences Inc, AstraZeneca Plc, JiangSu Qyuns Therapeutics Co Ltd, Leo Pharma AS, MD Healthcare Inc, Union Therapeutics AS, 3SBio Inc, and Aslan Pharmaceuticals Ltd among others.

Atopic Dermatitis Pipeline Drugs Market, by Major Companies

Atopic Dermatitis Pipeline Drugs Market, by Major Companies

For more company insights, download a free sample report

Atopic Dermatitis Pipeline Drugs Market Overview

Key Targets Phosphodiesterase 4, Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, Filaggrin, Liver X Receptor, 16S Ribosomal RNA, Angiopoietin 1 Receptor, and Caspase 1
Key Mechanisms of action Phosphodiesterase 4 Inhibitor, Tyrosine Protein Kinase JAK1 Inhibitor, Interleukin 4 Receptor Subunit Alpha Antagonist, Interleukin 13 Inhibitor, Sphingosine 1-Phosphate Receptor 1 Agonist, and Tyrosine Protein Kinase JAK3 Inhibitor
Key Routes of Administration Topical, Subcutaneous, Intravenous, Oral, Inhalational, Rectal, Ophthalmic, and Parenteral
Key molecule types Monoclonal Antibody, Small Molecule, Recombinant Protein, Fusion Protein, Cell Therapy, Synthetic Peptide, and Biologic
Major companies Pfizer Inc, Bristol-Myers Squibb Co, Dermavant Sciences Inc, AstraZeneca Plc, JiangSu Qyuns Therapeutics Co Ltd, Leo Pharma AS, MD Healthcare Inc, Union Therapeutics AS, 3SBio Inc, and Aslan Pharmaceuticals Ltd

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Atopic Dermatitis
  • The pipeline guide reviews pipeline therapeutics for Atopic Dermatitis by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Atopic Dermatitis therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Atopic Dermatitis therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews the latest news related to pipeline therapeutics for Atopic Dermatitis

Reasons to Buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Atopic Dermatitis
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Atopic Dermatitis pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.

3SBio Inc
Abate Med Inc
AbbVie Inc
Aclaris Therapeutics Inc
Adare Pharma Solutions
Akaal Pharma Pty Ltd
Akeso Inc
Alexion Pharmaceuticals Inc
Allakos Inc
Allergy Therapeutics Plc
Almirall SA
Amgen Inc
Amicogen Inc
Amorepacific Corp
Amtixbio Co Ltd
Amytrx Therapeutics Inc
Annji Pharmaceutical Co Ltd
AOBiome LLC
Apimeds Inc
Arcutis Biotherapeutics Inc
Arrien Pharmaceuticals LLC
Asana BioSciences LLC
Aslan Pharmaceuticals Ltd
Astellas Pharma Inc
AstraZeneca Plc
Atrapos Therapeutics LLC
Attillaps Holdings Inc
Avixgen Inc
Azitra Inc
Bausch Health Companies Inc
Beijing Puqi Pharmaceutical Technology Co Ltd
BenevolentAI Ltd
BioMarck Pharmaceuticals Ltd
BioMe Inc
Biomimetix JV LLC
BiomX Inc
Biosion Inc
Bioversys AG
Biozeus Pharmaceutical SA
Blueberry Therapeutics Ltd
Boehringer Ingelheim International GmbH
Boryung ViGenCell Inc
Botanix Pharmaceuticals Ltd
Brandenburg Antiinfektiva GmbH
Brexogen Inc
Brickell Biotech Inc
Bristol-Myers Squibb Co
Cellivery Therapeutics Inc
CELLnLIFE Inc
Chugai Pharmaceutical Co Ltd
Clayton Biotechnologies Inc
Clevexel Pharma SA
CSA Biotechnologies LLC
Cugene Inc
Curexsys GmbH
Cutanea Life Sciences Inc
Daiichi Sankyo Co Ltd
Derm-Biome Pharmaceuticals Inc
Dermala Inc
Dermavant Sciences Inc
DermBiont Inc
Devonian Health Group Inc
DongKoo Bio & Pharma Co Ltd
EHL Bio Co Ltd
Eli Lilly and Co
Emerald Biotechnology Espana
Enitiate Biopharmaceuticals (Hangzhou) Co Ltd
Enzychem Lifesciences Corp
Epigen Biosciences Inc
Evelo Biosciences Inc
Evommune Inc
Evotec SE
F. Hoffmann-La Roche Ltd
Galapagos NV
General Regeneratives Shanghai Ltd
Genrix (Shanghai) Biopharmaceutical Co Ltd
GI Innovation Co Ltd
GL Pharm Tech Corp
GlaxoSmithKline Plc
Hefei Medical & Pharmaceutical Co Ltd
Hill Dermaceuticals Inc
Hoth Therapeutics Inc
Huons Co Ltd
Ichnos Sciences Inc
Immune Pharmaceuticals Inc
Incyte Corp
Inflamalps SA
Ingenew Pharmaceuticals Inc
Inmagene Biopharmaceuticals Ltd
InnoCare Pharma Ltd
InnoPharmaScreen Inc
Innovation Pharmaceuticals Inc
Innovimmune Biotherapeutics Inc
Integral Molecular Inc
Intrinsic Medicine Inc
Japan Tobacco Inc
Jiangsu Hengrui Medicine Co Ltd
JiangSu Qyuns Therapeutics Co Ltd
Johnson & Johnson
Jubilant Therapeutics Inc
Jupiter Wellness Inc
JW Pharmaceutical Corp
Kangstem Biotech Co Ltd
KeyMed Biosciences Inc
Kine Sciences
Kiniksa Pharmaceuticals Ltd
KoBioLabs Inc
Krystal Biotech Inc
Kymab Ltd
Kymera Therapeutics, Inc
Kyowa Kirin Co Ltd
Landos Biopharma Inc
Lanier Biotherapeutics Inc
Larix Bioscience LLC
Lead Pharma Holding BV
Leo Pharma AS
LG Chem Ltd
Liminal BioSciences Inc
Lipidor AB
Lynk Pharmaceutical Hangzhou Co Ltd
Mabwell Shanghai Bioscience Co Ltd
Maruho Co Ltd
Matrisys Bioscience Inc
MC2 Therapeutics AS
MD Healthcare Inc
Medicenna Therapeutics Corp
Micreos BV
Midatech Pharma Plc
Minghui Pharmaceutical (Shanghai) Co Ltd
Nanjing Aimeifei Biomedical Technology Co Ltd
Nektar Therapeutics
Neovacs SA
Nepsone ehf
Neuracle Science Co Ltd
Next Science Ltd
NextPhase Therapeutics
NovaCell Technology Inc
Novan Inc
NovaRock Biotherapeutics Inc
Novartis AG
Numab Therapeutics AG
Oasis Pharmaceuticals LLC
OliX Pharmaceuticals Inc
OM Pharma Ltd
Oncocross Co Ltd
Ondek Pty Ltd
Oneness Biotech Co Ltd
Orgenesis Inc
Otsuka Pharmaceutical Co Ltd
Panolos Bioscience
Pantherics Inc
PeLeMed Co Ltd
Pfizer Inc
PrimeGen Global Inc
Principia Biopharma Inc
Provectus Biopharmaceuticals Inc
Pyramid Biosciences Inc
Qurient Co Ltd
Ralexar Therapeutics Inc
RAPT Therapeutics Inc
Regeneron Pharmaceuticals Inc
Regeneus Ltd
Regranion LLC
Rhizen Pharmaceuticals SA
Ribomic Inc
Ribon Therapeutics Inc
Rudacure Co Ltd
Sanofi
SCM lifescience Co Ltd
Seanergy Dermatology Ltd
Seelos Therapeutics, Inc.
Servatus Ltd
Shandong Boan Biotechnology Co Ltd
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Shanghai Maiji Biotechnology Co Ltd
Shaperon Inc
Shenzhen Forward Pharmaceutical Co Ltd
Shulov Innovative Science Ltd
Signum Biosciences Inc
Signum Dermalogix Inc
Siolta Therapeutics Inc
siRNAgen Therapeutics Corp
Sosei Group Corp
StemRIM Inc
Sun Pharmaceutical Industries Ltd
Suzhou Connect Biopharmaceuticals Ltd
Suzhou Longbote Pharmaceutical Co Ltd
Suzhou Zelgen Biopharmaceutical Co Ltd
TaiwanJ Pharmaceuticals Co Ltd
Technoderma Medicines Inc
Temisis Therapeutics
TeraImmune Inc
Teres Bio Inc
The Geneva Biotech Center SA
The United Laboratories International Holdings Ltd
Therabest Co Ltd
Tianjin Hemay Pharmaceutical Co Ltd
Tirmed Pharma AB
Torrent Pharmaceuticals Ltd
Transdermal Therapeutic Technologies LLC
TRPblue Inc
TWi Biotechnology Inc
UCB SA
Union Therapeutics AS
United Biomedical Inc
Vasomune Inc
vTv Therapeutics Inc
VYNE Therapeutics Inc
Welichem Biotech Inc
YIRUI Pharmaceutical Technology Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Atopic Dermatitis (Atopic Eczema) – Overview

Atopic Dermatitis (Atopic Eczema) – Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Atopic Dermatitis (Atopic Eczema) – Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Atopic Dermatitis (Atopic Eczema) – Companies Involved in Therapeutics Development

Atopic Dermatitis (Atopic Eczema) – Drug Profiles

Atopic Dermatitis (Atopic Eczema) – Dormant Projects

Atopic Dermatitis (Atopic Eczema) – Discontinued Products

Atopic Dermatitis (Atopic Eczema) – Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

Table

List of Tables

Number of Products under Development for Atopic Dermatitis (Atopic Eczema), 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Companies, 2022 (Contd..1)

Number of Products under Development by Companies, 2022 (Contd..2)

Number of Products under Development by Companies, 2022 (Contd..3)

Number of Products under Development by Companies, 2022 (Contd..4)

Number of Products under Development by Companies, 2022 (Contd..5)

Number of Products under Development by Companies, 2022 (Contd..6)

Number of Products under Development by Companies, 2022 (Contd..7)

Number of Products under Development by Companies, 2022 (Contd..8)

Number of Products under Development by Companies, 2022 (Contd..9)

Number of Products under Development by Companies, 2022 (Contd..10)

Number of Products under Development by Universities/Institutes, 2022

Products under Development by Companies, 2022

Products under Development by Companies, 2022 (Contd..1)

Products under Development by Companies, 2022 (Contd..2)

Products under Development by Companies, 2022 (Contd..3)

Products under Development by Companies, 2022 (Contd..4)

Products under Development by Companies, 2022 (Contd..5)

Products under Development by Companies, 2022 (Contd..6)

Products under Development by Companies, 2022 (Contd..7)

Products under Development by Companies, 2022 (Contd..8)

Products under Development by Companies, 2022 (Contd..9)

Products under Development by Companies, 2022 (Contd..10)

Products under Development by Companies, 2022 (Contd..11)

Products under Development by Companies, 2022 (Contd..12)

Products under Development by Companies, 2022 (Contd..13)

Products under Development by Companies, 2022 (Contd..14)

Products under Development by Companies, 2022 (Contd..15)

Products under Development by Companies, 2022 (Contd..16)

Products under Development by Universities/Institutes, 2022

Number of Products by Stage and Target, 2022

Number of Products by Stage and Target, 2022 (Contd..1)

Number of Products by Stage and Target, 2022 (Contd..2)

Number of Products by Stage and Target, 2022 (Contd..3)

Number of Products by Stage and Target, 2022 (Contd..4)

Number of Products by Stage and Mechanism of Action, 2022

Number of Products by Stage and Mechanism of Action, 2022 (Contd..1)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..2)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..3)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..4)

Number of Products by Stage and Route of Administration, 2022

Number of Products by Stage and Molecule Type, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by 3SBio Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Abate Med Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by AbbVie Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Aclaris Therapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Adare Pharma Solutions, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Akaal Pharma Pty Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Akeso Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Alexion Pharmaceuticals Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Allakos Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Allergy Therapeutics Plc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Almirall SA, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Amgen Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Amicogen Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Amorepacific Corp, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Amtixbio Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Amytrx Therapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Annji Pharmaceutical Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by AOBiome LLC, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Apimeds Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Arcutis Biotherapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Arrien Pharmaceuticals LLC, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Asana BioSciences LLC, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Aslan Pharmaceuticals Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Astellas Pharma Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by AstraZeneca Plc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Atrapos Therapeutics LLC, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Attillaps Holdings Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Avixgen Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Azitra Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Bausch Health Companies Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Beijing Puqi Pharmaceutical Technology Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by BenevolentAI Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by BioMarck Pharmaceuticals Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by BioMe Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Biomimetix JV LLC, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by BiomX Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Biosion Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Bioversys AG, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Biozeus Pharmaceutical SA, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Blueberry Therapeutics Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Boehringer Ingelheim International GmbH, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Boryung ViGenCell Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Botanix Pharmaceuticals Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Brandenburg Antiinfektiva GmbH, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Brexogen Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Brickell Biotech Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Bristol-Myers Squibb Co, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Cellivery Therapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by CELLnLIFE Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Chugai Pharmaceutical Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Clayton Biotechnologies Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Clevexel Pharma SA, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by CSA Biotechnologies LLC, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Cugene Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Curexsys GmbH, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Cutanea Life Sciences Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Daiichi Sankyo Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Derm-Biome Pharmaceuticals Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Dermala Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Dermavant Sciences Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by DermBiont Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Devonian Health Group Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by DongKoo Bio & Pharma Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by EHL Bio Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Eli Lilly and Co, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Emerald Biotechnology Espana, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Enitiate Biopharmaceuticals (Hangzhou) Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Enzychem Lifesciences Corp, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Epigen Biosciences Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Evelo Biosciences Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Evommune Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Evotec SE, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by F. Hoffmann-La Roche Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Galapagos NV, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by General Regeneratives Shanghai Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Genrix (Shanghai) Biopharmaceutical Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by GI Innovation Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by GL Pharm Tech Corp, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by GlaxoSmithKline Plc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Hefei Medical & Pharmaceutical Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Hill Dermaceuticals Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Hoth Therapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Huons Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Ichnos Sciences Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Immune Pharmaceuticals Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Incyte Corp, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Inflamalps SA, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Ingenew Pharmaceuticals Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Inmagene Biopharmaceuticals Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by InnoCare Pharma Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by InnoPharmaScreen Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Innovation Pharmaceuticals Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Innovimmune Biotherapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Integral Molecular Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Intrinsic Medicine Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Japan Tobacco Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by JiangSu Qyuns Therapeutics Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Johnson & Johnson, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Jubilant Therapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Jupiter Wellness Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by JW Pharmaceutical Corp, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Kangstem Biotech Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by KeyMed Biosciences Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Kine Sciences, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Kiniksa Pharmaceuticals Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by KoBioLabs Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Krystal Biotech Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Kymab Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Kymera Therapeutics, Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Kyowa Kirin Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Landos Biopharma Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Lanier Biotherapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Larix Bioscience LLC, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Lead Pharma Holding BV, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Leo Pharma AS, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by LG Chem Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Liminal BioSciences Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Lipidor AB, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Lynk Pharmaceutical Hangzhou Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Mabwell Shanghai Bioscience Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Maruho Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Matrisys Bioscience Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by MC2 Therapeutics AS, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by MD Healthcare Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Medicenna Therapeutics Corp, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Micreos BV, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Midatech Pharma Plc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Minghui Pharmaceutical (Shanghai) Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Nanjing Aimeifei Biomedical Technology Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Nektar Therapeutics, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Neovacs SA, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Nepsone ehf, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Neuracle Science Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Next Science Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by NextPhase Therapeutics, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by NovaCell Technology Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Novan Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by NovaRock Biotherapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Novartis AG, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Numab Therapeutics AG, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Oasis Pharmaceuticals LLC, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by OliX Pharmaceuticals Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by OM Pharma Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Oncocross Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Ondek Pty Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Oneness Biotech Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Orgenesis Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Otsuka Pharmaceutical Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Panolos Bioscience, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Pantherics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by PeLeMed Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Pfizer Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by PrimeGen Global Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Principia Biopharma Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Provectus Biopharmaceuticals Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Pyramid Biosciences Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Qurient Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Ralexar Therapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by RAPT Therapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Regeneron Pharmaceuticals Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Regeneus Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Regranion LLC, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Rhizen Pharmaceuticals SA, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Ribomic Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Ribon Therapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Rudacure Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Sanofi, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by SCM lifescience Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Seanergy Dermatology Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Seelos Therapeutics, Inc., 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Servatus Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Shandong Boan Biotechnology Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Shanghai Maiji Biotechnology Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Shaperon Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Shenzhen Forward Pharmaceutical Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Shulov Innovative Science Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Signum Biosciences Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Signum Dermalogix Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Siolta Therapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by siRNAgen Therapeutics Corp, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Sosei Group Corp, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by StemRIM Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Sun Pharmaceutical Industries Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Suzhou Connect Biopharmaceuticals Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Suzhou Longbote Pharmaceutical Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Suzhou Zelgen Biopharmaceutical Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by TaiwanJ Pharmaceuticals Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Technoderma Medicines Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Temisis Therapeutics, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by TeraImmune Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Teres Bio Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by The Geneva Biotech Center SA, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by The United Laboratories International Holdings Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Therabest Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Tianjin Hemay Pharmaceutical Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Tirmed Pharma AB, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Torrent Pharmaceuticals Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Transdermal Therapeutic Technologies LLC, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by TRPblue Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by TWi Biotechnology Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by UCB SA, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Union Therapeutics AS, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by United Biomedical Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Vasomune Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by vTv Therapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by VYNE Therapeutics Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by Welichem Biotech Inc, 2022

Atopic Dermatitis (Atopic Eczema) – Pipeline by YIRUI Pharmaceutical Technology Co Ltd, 2022

Atopic Dermatitis (Atopic Eczema) – Dormant Projects, 2022

Atopic Dermatitis (Atopic Eczema) – Dormant Projects, 2022 (Contd..1)

Atopic Dermatitis (Atopic Eczema) – Dormant Projects, 2022 (Contd..2)

Atopic Dermatitis (Atopic Eczema) – Dormant Projects, 2022 (Contd..3)

Atopic Dermatitis (Atopic Eczema) – Dormant Projects, 2022 (Contd..4)

Atopic Dermatitis (Atopic Eczema) – Dormant Projects, 2022 (Contd..5)

Atopic Dermatitis (Atopic Eczema) – Dormant Projects, 2022 (Contd..6)

Atopic Dermatitis (Atopic Eczema) – Dormant Projects, 2022 (Contd..7)

Atopic Dermatitis (Atopic Eczema) – Dormant Projects, 2022 (Contd..8)

Atopic Dermatitis (Atopic Eczema) – Dormant Projects, 2022 (Contd..9)

Atopic Dermatitis (Atopic Eczema) – Dormant Projects, 2022 (Contd..10)

Atopic Dermatitis (Atopic Eczema) – Discontinued Products, 2022

Atopic Dermatitis (Atopic Eczema) – Discontinued Products, 2022 (Contd..1)

Figures

List of Figures

Number of Products under Development for Atopic Dermatitis (Atopic Eczema), 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Universities/Institutes, 2022

Number of Products by Top 10 Targets, 2022

Number of Products by Stage and Top 10 Targets, 2022

Number of Products by Top 10 Mechanism of Actions, 2022

Number of Products by Stage and Top 10 Mechanism of Actions, 2022

Number of Products by Top 10 Routes of Administration, 2022

Number of Products by Stage and Top 10 Routes of Administration, 2022

Number of Products by Top 10 Molecule Types, 2022

Number of Products by Stage and Top 10 Molecule Types, 2022

Frequently asked questions

Atopic Dermatitis (Atopic Eczema) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update thematic reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Atopic Dermatitis (Atopic Eczema) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update in real time.

  • Access a live Atopic Dermatitis (Atopic Eczema) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.